The ascendancy of Viagra and its impact on the medicinal landscape presents a complex question for shareholders. While the first sales figures were impressive, the patent has ended, leading to a deluge of copycat https://dianegnei026509.aboutyoublog.com/53097028/the-blue-pill-and-the-pharmaceutical-industry-a-risky-investment